A scoping review of the pharmaceutical care needs of people with sensory impairment

Kirsty Killick, Leah Macaden, Annetta Smith, Thilo Kroll, Kathleen Stoddart, Margaret C. Watson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives
This scoping review collated evidence of the pharmaceutical care needs of people with sensory loss (SL).

Methods
Electronic databases were searched with no limit on year of publication: Medline (1946); Embase; Cinahl (1979); and Web of Science (1985). Search terms included the following: pharmacy; sight/hearing/dual impairment. Studies were included if they involved people with SL requiring pharmaceutical care and/or pharmacists/pharmacy support staff providing pharmaceutical care for people with SL. All study designs were eligible. This was a scoping review, and as such, the quality of studies was not formally evaluated.

Key findings
Eleven studies were included. People with SL had lower levels of medication knowledge than their peers without SL. People with SL were identified as being at higher risk of iatrogenic harm than people without SL. Communication was a barrier to the provision of pharmaceutical care for people with hearing loss, with pharmacists relying on the provision of written information. The prevalence of SL increases with age, yet only two studies included older people. No studies involved family or carers of people with SL, people with dual loss or people with SL receiving polypharmacy.

Conclusions
There is a paucity of data regarding the pharmaceutical care needs of people with SL. Unmet pharmaceutical care needs put people with SL at increased risk of harm from their medicines. A detailed understanding of the needs of people with SL is required which will inform future delivery of pharmaceutical care for this vulnerable population.
LanguageEnglish
Pages380-386
Number of pages7
JournalInternational Journal of Pharmacy Practice
Volume26
Issue number5
Early online date19 Jun 2018
DOIs
Publication statusPublished - 31 Oct 2018

Fingerprint

Pharmaceutical Services
Pharmaceutical Preparations
Hearing Loss
Pharmacists
Polypharmacy
Vulnerable Populations
Audition
Caregivers
Publications
Communication
Databases

Keywords

  • hearing loss
  • patient safety
  • pharmaceutical services
  • scoping review
  • vision disorders

Cite this

Killick, Kirsty ; Macaden, Leah ; Smith, Annetta ; Kroll, Thilo ; Stoddart, Kathleen ; Watson, Margaret C. / A scoping review of the pharmaceutical care needs of people with sensory impairment. In: International Journal of Pharmacy Practice. 2018 ; Vol. 26, No. 5. pp. 380-386.
@article{07e113e0eee74261830d8baee3cd1d81,
title = "A scoping review of the pharmaceutical care needs of people with sensory impairment",
abstract = "ObjectivesThis scoping review collated evidence of the pharmaceutical care needs of people with sensory loss (SL).MethodsElectronic databases were searched with no limit on year of publication: Medline (1946); Embase; Cinahl (1979); and Web of Science (1985). Search terms included the following: pharmacy; sight/hearing/dual impairment. Studies were included if they involved people with SL requiring pharmaceutical care and/or pharmacists/pharmacy support staff providing pharmaceutical care for people with SL. All study designs were eligible. This was a scoping review, and as such, the quality of studies was not formally evaluated.Key findingsEleven studies were included. People with SL had lower levels of medication knowledge than their peers without SL. People with SL were identified as being at higher risk of iatrogenic harm than people without SL. Communication was a barrier to the provision of pharmaceutical care for people with hearing loss, with pharmacists relying on the provision of written information. The prevalence of SL increases with age, yet only two studies included older people. No studies involved family or carers of people with SL, people with dual loss or people with SL receiving polypharmacy.ConclusionsThere is a paucity of data regarding the pharmaceutical care needs of people with SL. Unmet pharmaceutical care needs put people with SL at increased risk of harm from their medicines. A detailed understanding of the needs of people with SL is required which will inform future delivery of pharmaceutical care for this vulnerable population.",
keywords = "hearing loss, patient safety, pharmaceutical services, scoping review, vision disorders",
author = "Kirsty Killick and Leah Macaden and Annetta Smith and Thilo Kroll and Kathleen Stoddart and Watson, {Margaret C.}",
year = "2018",
month = "10",
day = "31",
doi = "10.1111/ijpp.12456",
language = "English",
volume = "26",
pages = "380--386",
journal = "International Journal of Pharmacy Practice",
issn = "0961-7671",
number = "5",

}

A scoping review of the pharmaceutical care needs of people with sensory impairment. / Killick, Kirsty; Macaden, Leah; Smith, Annetta; Kroll, Thilo; Stoddart, Kathleen; Watson, Margaret C.

In: International Journal of Pharmacy Practice, Vol. 26, No. 5, 31.10.2018, p. 380-386.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A scoping review of the pharmaceutical care needs of people with sensory impairment

AU - Killick, Kirsty

AU - Macaden, Leah

AU - Smith, Annetta

AU - Kroll, Thilo

AU - Stoddart, Kathleen

AU - Watson, Margaret C.

PY - 2018/10/31

Y1 - 2018/10/31

N2 - ObjectivesThis scoping review collated evidence of the pharmaceutical care needs of people with sensory loss (SL).MethodsElectronic databases were searched with no limit on year of publication: Medline (1946); Embase; Cinahl (1979); and Web of Science (1985). Search terms included the following: pharmacy; sight/hearing/dual impairment. Studies were included if they involved people with SL requiring pharmaceutical care and/or pharmacists/pharmacy support staff providing pharmaceutical care for people with SL. All study designs were eligible. This was a scoping review, and as such, the quality of studies was not formally evaluated.Key findingsEleven studies were included. People with SL had lower levels of medication knowledge than their peers without SL. People with SL were identified as being at higher risk of iatrogenic harm than people without SL. Communication was a barrier to the provision of pharmaceutical care for people with hearing loss, with pharmacists relying on the provision of written information. The prevalence of SL increases with age, yet only two studies included older people. No studies involved family or carers of people with SL, people with dual loss or people with SL receiving polypharmacy.ConclusionsThere is a paucity of data regarding the pharmaceutical care needs of people with SL. Unmet pharmaceutical care needs put people with SL at increased risk of harm from their medicines. A detailed understanding of the needs of people with SL is required which will inform future delivery of pharmaceutical care for this vulnerable population.

AB - ObjectivesThis scoping review collated evidence of the pharmaceutical care needs of people with sensory loss (SL).MethodsElectronic databases were searched with no limit on year of publication: Medline (1946); Embase; Cinahl (1979); and Web of Science (1985). Search terms included the following: pharmacy; sight/hearing/dual impairment. Studies were included if they involved people with SL requiring pharmaceutical care and/or pharmacists/pharmacy support staff providing pharmaceutical care for people with SL. All study designs were eligible. This was a scoping review, and as such, the quality of studies was not formally evaluated.Key findingsEleven studies were included. People with SL had lower levels of medication knowledge than their peers without SL. People with SL were identified as being at higher risk of iatrogenic harm than people without SL. Communication was a barrier to the provision of pharmaceutical care for people with hearing loss, with pharmacists relying on the provision of written information. The prevalence of SL increases with age, yet only two studies included older people. No studies involved family or carers of people with SL, people with dual loss or people with SL receiving polypharmacy.ConclusionsThere is a paucity of data regarding the pharmaceutical care needs of people with SL. Unmet pharmaceutical care needs put people with SL at increased risk of harm from their medicines. A detailed understanding of the needs of people with SL is required which will inform future delivery of pharmaceutical care for this vulnerable population.

KW - hearing loss

KW - patient safety

KW - pharmaceutical services

KW - scoping review

KW - vision disorders

UR - https://onlinelibrary.wiley.com/journal/20427174

U2 - 10.1111/ijpp.12456

DO - 10.1111/ijpp.12456

M3 - Article

VL - 26

SP - 380

EP - 386

JO - International Journal of Pharmacy Practice

T2 - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

IS - 5

ER -